“Vaccines as control of emerging viruses and situation with SARS-CoV-2”
SPEAKER: Dr. Mariano Esteban
This July we continue with the telematics gathering modality, and we have invited a prestigious scientist, Dr Mariano Esteban Rodriguez, to talk to us about a topic of great concern to all of us, in the midst of de-escalation COVID19.
Our talk will be virtual, through the ZOOM platform. To attend you must pre-register before, in the form that appears when you open this link (by clicking on the link or copying it in the browser):
You will receive a Zoom notification with the final personal link that you must use to enter the session from 19.50:2 p.m. on June XNUMX. You must have downloaded the free application from www.zoom.us
We wish you all good health, and we look forward to seeing you on Tuesday, July 7.
mariano esteban, Ad Honorem Linked Research Professor of the National Center for Biotechnology (CNB) of the CSIC and Head of the Poxvirus and Vaccines group of the CNB. He is a native and favorite son of Villalón de Campos (Valladolid), he graduated in Pharmacy (1967) and in Biological Sciences (1972), obtaining the title of Doctor in 1970 in the specialty of Microbiology from the Faculty of Pharmacy, University of Santiago de Compose it. Between 1970-92 he worked in several research centers, among which the National Institute for Medical Research, London, (United Kingdom), at the Rutgers Medical School, New Jersey, (USA), at the Molecular Biology Institute, Ghent (Belgium), and at the Downstate Medical Center, SUNY, Brooklyn, New York, (USA) where he was Professor -professor- in the Departments of Biochemistry and Microbiology. He returned to Spain to direct during the period (1992-2003), since its inauguration, the National Center for Biotechnology (CNB-CSIC), a position he held for 11 years. He leads the "Poxvirus and Vaccines" group in the Department of Molecular and Cellular Biology of the National Center for Biotechnology (CNB-CSIC). Since 2013 he has chaired the Royal National Academy of Pharmacy (RANF), a position that he combines with that of vice president of the Institute of Spain - an institution that brings together the 8 Royal Academies of Spain - and that in October 2017 he will become president.
The interest of Mariano Esteban's research has focused on the knowledge of the molecular biology of pathogens such as viruses, in order to develop procedures that allow the control of infectious diseases. His discoveries about the biology of the vaccine virus, which was used as a vaccine to eradicate smallpox, have helped him generate new vaccines against prevalent diseases such as AIDS, hepatitis C, chikungunya virus, Ebola, Zika, malaria and leishmania, having been a pioneer in the field of vaccines by developing combined vector immunization procedures (prime/boost) that increase the cellular immune response and confer protection against different pathogens. These vaccination protocols are being tested in phase I/II clinical trials against pathogens and cancer. Esteban's scientific contributions on the mode of action of interferons have been pioneering, enhancing the clinical interest of these drugs as antiviral and antitumor agents. These scientific contributions represent 369 works published in international journals of impact, 11 patents, 34 doctoral theses and more than 350 communications in national and international congresses.
The ultimate goal is to obtain safe and effective vaccines against various human diseases such as AIDS, hepatitis C, chikungunya, Ebola, Zika, malaria, leishmania, Alzheimer's and cancer. Since January 2020, it has been developing a vaccine against COVID-19.
If you are interested in becoming a member of the Fulbright Association, you can write to us at email@example.com and/or inform you in http://asoc-fulbright.es/actividades-socios/quienes-somos/asociarse/